Sandy Spring Bank’s GSK GSK Stock Holding History

Sandy Spring Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$29.6K	Sell	765 -672	-47%	-$24.6K	﹤0.01%	667
2024 Q4	$48.6K	Sell	1,437 -528	-27%	-$19K	﹤0.01%	586
2024 Q3	$80.3K	Hold	1,965	–	–	﹤0.01%	500
2024 Q2	$75.7K	Hold	1,965	–	–	﹤0.01%	505
2024 Q1	$84.2K	Hold	1,965	–	–	﹤0.01%	492
2023 Q4	$72.8K	Hold	1,965	–	–	﹤0.01%	495
2023 Q3	$71.2K	Hold	1,965	–	–	﹤0.01%	486
2023 Q2	$70K	Buy	1,965 +355	+22%	+$12.7K	﹤0.01%	481
2023 Q1	$57.3K	Hold	1,610	–	–	﹤0.01%	512
2022 Q4	$56.6K	Hold	1,610	–	–	﹤0.01%	510
2022 Q3	$47K	Sell	1,610 -2,543	-61%	-$96.4K	﹤0.01%	521
2022 Q2	$226K	Buy	4,153 +359	+9%	+$19.8K	0.01%	317
2022 Q1	$207K	Buy	3,794 +846	+29%	+$46K	0.01%	331
2021 Q4	$163K	Buy	2,948 +80	+3%	+$4.16K	0.01%	363
2021 Q3	$137K	Sell	2,868 -1,943	-40%	-$97.6K	0.01%	375
2021 Q2	$240K	Sell	4,811 -1,000	-17%	-$48K	0.01%	318
2021 Q1	$259K	Sell	5,811 -83	-1%	-$3.77K	0.01%	299
2020 Q4	$271K	Hold	5,894	–	–	0.02%	287
2020 Q3	$278K	Hold	5,894	–	–	0.02%	271
2020 Q2	$300K	Hold	5,894	–	–	0.02%	260
2020 Q1	$279K	Sell	5,894 -108	-2%	-$5.76K	0.03%	255
2019 Q4	$352K	Sell	6,002 -252	-4%	-$14K	0.03%	255
2019 Q3	$333K	Sell	6,254 -198	-3%	-$10.2K	0.03%	258
2019 Q2	$323K	Sell	6,452 -760	-11%	-$38.1K	0.03%	251
2019 Q1	$377K	Sell	7,212 -936	-11%	-$46.8K	0.03%	236
2018 Q4	$389K	Sell	8,148 -1,309	-14%	-$64.5K	0.04%	232
2018 Q3	$475K	Sell	9,457 -6,101	-39%	-$310K	0.04%	229
2018 Q2	$784K	Hold	15,558	–	–	0.07%	202
2018 Q1	$760K	Buy	15,558 +6,214	+67%	+$289K	0.07%	207
2017 Q4	$415K	Sell	9,344 -1,305	-12%	-$60.3K	0.04%	230
2017 Q3	$540K	Buy	10,649 +317	+3%	+$16.1K	0.05%	216
2017 Q2	$557K	Buy	10,332 +120	+1%	+$6.4K	0.05%	213
2017 Q1	$539K	Sell	10,212 -222	-2%	-$11.3K	0.05%	219
2016 Q4	$502K	Buy	10,434 +222	+2%	+$11K	0.05%	224
2016 Q3	$550K	Buy	10,212 +224	+2%	+$12.3K	0.06%	216
2016 Q2	$542K	Sell	9,988 -313	-3%	-$16.5K	0.06%	211
2016 Q1	$522K	Buy	10,301 +33	+0.3%	+$1.64K	0.06%	211
2015 Q4	$518K	Sell	10,268 -323	-3%	-$16.5K	0.06%	214
2015 Q3	$509K	Buy	10,591 +988	+10%	+$51.4K	0.06%	213
2015 Q2	$500K	Buy	9,603 +528	+6%	+$29.7K	0.06%	221
2015 Q1	$523K	Buy	9,075 +6,172	+213%	+$354K	0.06%	208
2014 Q4	$155K	Sell	2,903 -160	-5%	-$8.95K	0.02%	287
2014 Q3	$176K	Buy	3,063 +1,034	+51%	+$63.4K	0.02%	285
2014 Q2	$136K	Hold	2,029	–	–	0.02%	302
2014 Q1	$135K	Buy	2,029 +211	+12%	+$14.3K	0.02%	283
2013 Q4	$121K	Hold	1,818	–	–	0.02%	298
2013 Q3	$114K	Hold	1,818	–	–	0.02%	287
2013 Q2	$114K	Buy	+1,818	New	+$115K	0.02%	274

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sandy Spring Bank's GSK Position: Q1 2025 in Review

Sandy Spring Bank reduced its GSK (GSK) stake by 47% in Q1 2025, selling an estimated $24.6K and leaving 765 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Sandy Spring Bank first reported a position in GSK in Q2 2013 and has held it in 48 quarters since. The position peaked at $784K in Q2 2018. 858 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

Sandy Spring Bank held 765 shares of GSK worth $29.6K as of Q1 2025.
Sandy Spring Bank sold 672 GSK shares in Q1 2025, an estimated $24.6K.
GSK made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #667 holding.
Sandy Spring Bank first reported a position in GSK in Q2 2013 and has held it in 48 quarters since.
Sandy Spring Bank's GSK position peaked at $784K in Q2 2018.
858 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.